People

Cindy Hespel

Cindy Hespel obtained her PhD in Immunology from the University of Brussels (ULB) in 2012 (Regulation of Adaptive Immune Responses by Conventional and Inflammatory Dendritic Cells). After her PhD, she began her career as Project Execution Manager (Global Medical Affairs Operations) at GlaxoSmithKline Vaccines for 2 years. She then moved to Bristol Myers Squibb as Clinical Trial-Global Submission Manager managing large portfolio across diverse Therapeutic Areas for 7 years before joining Bioxodes as Regulatory Affairs Manager in 2021.